B-Tech Vectors are made by modifying a highly secreted B.pertussis surface protein. The target antigen is genetically added to the carrier protein DNA, and both proteins are produced and secreted in large amounts on the surface of the vector. This results in potent antigen specific mucosal and systemic immune responses to the target antigen.
The B-Tech Vector Platform can be modified to express antigens from various pathogen and cancer targets.